| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammography | 39 | 2025 | 290 | 7.820 |
Why?
|
| Breast Neoplasms | 24 | 2025 | 1222 | 5.130 |
Why?
|
| Cone-Beam Computed Tomography | 15 | 2025 | 71 | 5.030 |
Why?
|
| Breast | 19 | 2025 | 191 | 4.180 |
Why?
|
| Tomography, X-Ray Computed | 16 | 2025 | 1656 | 2.510 |
Why?
|
| Radiation Dosage | 13 | 2025 | 139 | 2.310 |
Why?
|
| Image Processing, Computer-Assisted | 17 | 2025 | 699 | 2.260 |
Why?
|
| Algorithms | 19 | 2025 | 1048 | 2.150 |
Why?
|
| Phantoms, Imaging | 21 | 2025 | 235 | 2.010 |
Why?
|
| Radiographic Image Enhancement | 18 | 2018 | 98 | 1.890 |
Why?
|
| Scattering, Radiation | 7 | 2025 | 72 | 1.300 |
Why?
|
| Imaging, Three-Dimensional | 8 | 2023 | 298 | 1.090 |
Why?
|
| Diabetes, Gestational | 2 | 2019 | 142 | 1.000 |
Why?
|
| Glycation End Products, Advanced | 4 | 2024 | 19 | 1.000 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2025 | 2244 | 0.920 |
Why?
|
| Radiometry | 4 | 2022 | 39 | 0.900 |
Why?
|
| Early Growth Response Protein 1 | 3 | 2019 | 17 | 0.880 |
Why?
|
| Monte Carlo Method | 11 | 2025 | 98 | 0.870 |
Why?
|
| Models, Theoretical | 4 | 2014 | 274 | 0.840 |
Why?
|
| Female | 51 | 2026 | 34008 | 0.830 |
Why?
|
| X-Ray Diffraction | 2 | 2014 | 61 | 0.810 |
Why?
|
| Humans | 73 | 2026 | 65109 | 0.770 |
Why?
|
| Mastectomy, Segmental | 1 | 2022 | 48 | 0.720 |
Why?
|
| Early Detection of Cancer | 7 | 2024 | 325 | 0.710 |
Why?
|
| X-Rays | 9 | 2022 | 46 | 0.690 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 6 | 2012 | 76 | 0.660 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 211 | 0.590 |
Why?
|
| Photons | 2 | 2016 | 23 | 0.590 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2017 | 139 | 0.580 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2019 | 45 | 0.580 |
Why?
|
| Sensitivity and Specificity | 14 | 2022 | 1163 | 0.570 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2019 | 234 | 0.550 |
Why?
|
| Biosensing Techniques | 4 | 2023 | 126 | 0.540 |
Why?
|
| Retrospective Studies | 20 | 2025 | 6860 | 0.540 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 235 | 0.520 |
Why?
|
| Reproducibility of Results | 12 | 2023 | 1698 | 0.510 |
Why?
|
| Tellurium | 1 | 2016 | 5 | 0.490 |
Why?
|
| Cadmium Compounds | 1 | 2016 | 25 | 0.480 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2016 | 23 | 0.480 |
Why?
|
| Pyruvaldehyde | 4 | 2023 | 6 | 0.470 |
Why?
|
| Hyperostosis Frontalis Interna | 2 | 2025 | 2 | 0.460 |
Why?
|
| Workload | 2 | 2026 | 130 | 0.440 |
Why?
|
| Linear Models | 5 | 2020 | 405 | 0.430 |
Why?
|
| Radiologists | 3 | 2026 | 93 | 0.430 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 272 | 0.430 |
Why?
|
| Radiology | 3 | 2025 | 263 | 0.420 |
Why?
|
| Artifacts | 4 | 2024 | 126 | 0.420 |
Why?
|
| Angiography | 2 | 2004 | 154 | 0.410 |
Why?
|
| Biomimetics | 1 | 2013 | 31 | 0.380 |
Why?
|
| Pattern Recognition, Automated | 1 | 2012 | 52 | 0.380 |
Why?
|
| Precision Medicine | 1 | 2013 | 129 | 0.370 |
Why?
|
| Equipment Design | 7 | 2013 | 363 | 0.360 |
Why?
|
| Burnout, Professional | 2 | 2026 | 142 | 0.350 |
Why?
|
| Intracranial Aneurysm | 5 | 2017 | 382 | 0.340 |
Why?
|
| Equipment Failure Analysis | 4 | 2013 | 78 | 0.330 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2019 | 54 | 0.330 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2011 | 44 | 0.330 |
Why?
|
| Silicon | 2 | 2000 | 17 | 0.320 |
Why?
|
| Defecography | 2 | 2021 | 3 | 0.320 |
Why?
|
| Radiography | 2 | 2021 | 555 | 0.310 |
Why?
|
| Pelvic Organ Prolapse | 2 | 2021 | 30 | 0.300 |
Why?
|
| Fluoroscopy | 3 | 2017 | 67 | 0.290 |
Why?
|
| Ultrasonography | 3 | 2018 | 489 | 0.290 |
Why?
|
| Stents | 4 | 2017 | 498 | 0.280 |
Why?
|
| Radionuclide Imaging | 2 | 2024 | 128 | 0.270 |
Why?
|
| Endovascular Procedures | 3 | 2023 | 626 | 0.270 |
Why?
|
| Adult | 17 | 2026 | 17353 | 0.270 |
Why?
|
| Transducers | 2 | 2005 | 23 | 0.270 |
Why?
|
| Electrochemical Techniques | 2 | 2017 | 21 | 0.260 |
Why?
|
| Biomarkers | 3 | 2024 | 1479 | 0.260 |
Why?
|
| Computer Simulation | 9 | 2021 | 483 | 0.250 |
Why?
|
| Calcinosis | 4 | 2018 | 84 | 0.250 |
Why?
|
| Skull Fractures | 2 | 2017 | 20 | 0.240 |
Why?
|
| Retirement | 1 | 2026 | 21 | 0.230 |
Why?
|
| Brain | 3 | 2025 | 1603 | 0.230 |
Why?
|
| Neuroradiography | 1 | 2025 | 11 | 0.230 |
Why?
|
| Lymphatic Metastasis | 2 | 2023 | 90 | 0.230 |
Why?
|
| Middle Aged | 16 | 2026 | 18262 | 0.220 |
Why?
|
| Diagnostic Errors | 1 | 2026 | 105 | 0.220 |
Why?
|
| Gangliosidosis, GM1 | 1 | 2025 | 26 | 0.220 |
Why?
|
| Contrast Media | 3 | 2025 | 432 | 0.220 |
Why?
|
| Fellowships and Scholarships | 1 | 2025 | 105 | 0.210 |
Why?
|
| Quality Control | 1 | 2024 | 78 | 0.210 |
Why?
|
| Cross-Over Studies | 1 | 2024 | 164 | 0.210 |
Why?
|
| Medical Errors | 1 | 2026 | 202 | 0.200 |
Why?
|
| Feasibility Studies | 4 | 2020 | 587 | 0.200 |
Why?
|
| Radar | 1 | 2022 | 4 | 0.190 |
Why?
|
| Wireless Technology | 1 | 2022 | 14 | 0.190 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2022 | 6 | 0.190 |
Why?
|
| Overweight | 1 | 2024 | 257 | 0.180 |
Why?
|
| Thromboplastin | 2 | 2019 | 6 | 0.180 |
Why?
|
| Pregnancy | 2 | 2019 | 2374 | 0.180 |
Why?
|
| Models, Anatomic | 3 | 2016 | 62 | 0.170 |
Why?
|
| Aged | 13 | 2025 | 14952 | 0.170 |
Why?
|
| Heart-Assist Devices | 1 | 2024 | 158 | 0.170 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2020 | 187 | 0.170 |
Why?
|
| Insulin Resistance | 1 | 2024 | 414 | 0.170 |
Why?
|
| Up-Regulation | 2 | 2019 | 373 | 0.170 |
Why?
|
| Biopsy | 1 | 2022 | 456 | 0.170 |
Why?
|
| Blood Glucose | 2 | 2024 | 497 | 0.170 |
Why?
|
| Breast Diseases | 2 | 2014 | 45 | 0.160 |
Why?
|
| Case-Control Studies | 2 | 2025 | 1141 | 0.160 |
Why?
|
| Gold | 2 | 2019 | 235 | 0.160 |
Why?
|
| Young Adult | 5 | 2025 | 4810 | 0.150 |
Why?
|
| Video Recording | 1 | 2000 | 139 | 0.150 |
Why?
|
| Signal Processing, Computer-Assisted | 3 | 2006 | 99 | 0.150 |
Why?
|
| Alloys | 2 | 2016 | 30 | 0.150 |
Why?
|
| Osteomyelitis | 1 | 2019 | 24 | 0.150 |
Why?
|
| Foot | 1 | 2019 | 42 | 0.150 |
Why?
|
| Insulins | 1 | 2019 | 15 | 0.150 |
Why?
|
| Protein Kinase C beta | 1 | 2019 | 6 | 0.150 |
Why?
|
| Male | 16 | 2026 | 31025 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2019 | 42 | 0.150 |
Why?
|
| Vascular Malformations | 1 | 2019 | 22 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2019 | 46 | 0.150 |
Why?
|
| Morphogenesis | 1 | 2019 | 120 | 0.150 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2019 | 38 | 0.140 |
Why?
|
| Skin | 2 | 2013 | 422 | 0.140 |
Why?
|
| Abdominal Neoplasms | 1 | 2018 | 22 | 0.140 |
Why?
|
| Protein Isoforms | 1 | 2019 | 202 | 0.140 |
Why?
|
| Femoral Artery | 1 | 2019 | 104 | 0.140 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2019 | 206 | 0.140 |
Why?
|
| Carcinoma, Lobular | 1 | 2018 | 26 | 0.140 |
Why?
|
| Adolescent | 7 | 2025 | 6305 | 0.140 |
Why?
|
| Abdomen | 1 | 2018 | 94 | 0.140 |
Why?
|
| Antigens, Neoplasm | 1 | 2019 | 136 | 0.140 |
Why?
|
| Physical Examination | 1 | 2018 | 109 | 0.140 |
Why?
|
| Appendicitis | 1 | 2019 | 84 | 0.140 |
Why?
|
| Retinal Vessels | 1 | 2018 | 18 | 0.140 |
Why?
|
| Postoperative Care | 1 | 2018 | 125 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2019 | 213 | 0.130 |
Why?
|
| Models, Biological | 3 | 2007 | 1192 | 0.130 |
Why?
|
| Meglumine | 1 | 2017 | 21 | 0.130 |
Why?
|
| Nephrogenic Fibrosing Dermopathy | 1 | 2017 | 22 | 0.130 |
Why?
|
| Pneumocephalus | 1 | 2017 | 5 | 0.130 |
Why?
|
| Temporal Bone | 1 | 2017 | 11 | 0.130 |
Why?
|
| Food Analysis | 1 | 2017 | 32 | 0.130 |
Why?
|
| Preoperative Care | 1 | 2018 | 199 | 0.130 |
Why?
|
| Tomography | 2 | 2007 | 8 | 0.130 |
Why?
|
| Self Expandable Metallic Stents | 1 | 2017 | 33 | 0.130 |
Why?
|
| Metal Nanoparticles | 1 | 2019 | 190 | 0.130 |
Why?
|
| Peptide Fragments | 1 | 2019 | 417 | 0.130 |
Why?
|
| Hyperglycemia | 1 | 2018 | 104 | 0.130 |
Why?
|
| Organometallic Compounds | 1 | 2017 | 71 | 0.130 |
Why?
|
| Diabetic Retinopathy | 1 | 2018 | 60 | 0.120 |
Why?
|
| Oryza | 1 | 2017 | 36 | 0.120 |
Why?
|
| Organ Size | 2 | 2016 | 173 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 731 | 0.120 |
Why?
|
| Polymethyl Methacrylate | 1 | 2016 | 15 | 0.120 |
Why?
|
| Obesity | 1 | 2024 | 1273 | 0.120 |
Why?
|
| Endothelial Cells | 1 | 2018 | 207 | 0.120 |
Why?
|
| Wrist | 1 | 2016 | 39 | 0.120 |
Why?
|
| Radiography, Interventional | 1 | 2017 | 82 | 0.120 |
Why?
|
| Cerebrovascular Disorders | 1 | 2017 | 83 | 0.120 |
Why?
|
| Renal Dialysis | 1 | 2017 | 191 | 0.120 |
Why?
|
| Fingers | 1 | 2016 | 48 | 0.120 |
Why?
|
| Shear Strength | 1 | 2015 | 19 | 0.120 |
Why?
|
| Blood Vessels | 1 | 2016 | 63 | 0.120 |
Why?
|
| Prosthesis Design | 1 | 2016 | 219 | 0.120 |
Why?
|
| Lymph Nodes | 1 | 2016 | 232 | 0.120 |
Why?
|
| Tissue Scaffolds | 1 | 2016 | 90 | 0.110 |
Why?
|
| Nanostructures | 1 | 2017 | 188 | 0.110 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 178 | 0.110 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2017 | 147 | 0.110 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2015 | 67 | 0.110 |
Why?
|
| X-Ray Intensifying Screens | 2 | 2013 | 8 | 0.110 |
Why?
|
| Cerebral Angiography | 1 | 2017 | 299 | 0.110 |
Why?
|
| Tissue Engineering | 1 | 2016 | 148 | 0.110 |
Why?
|
| Interferometry | 1 | 2014 | 4 | 0.110 |
Why?
|
| Thrombosis | 1 | 2017 | 206 | 0.110 |
Why?
|
| Mesophyll Cells | 1 | 2014 | 2 | 0.110 |
Why?
|
| Biopsy, Needle | 1 | 2015 | 134 | 0.110 |
Why?
|
| Glucose | 1 | 2018 | 476 | 0.110 |
Why?
|
| Signal-To-Noise Ratio | 3 | 2020 | 61 | 0.110 |
Why?
|
| Stroke | 1 | 2023 | 1209 | 0.100 |
Why?
|
| Limit of Detection | 3 | 2019 | 49 | 0.100 |
Why?
|
| Models, Statistical | 4 | 2018 | 309 | 0.100 |
Why?
|
| Peroxidase | 1 | 2014 | 70 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 555 | 0.100 |
Why?
|
| Prone Position | 1 | 2013 | 28 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2021 | 805 | 0.100 |
Why?
|
| Child | 5 | 2025 | 4612 | 0.100 |
Why?
|
| Aneurysm, Ruptured | 1 | 2014 | 82 | 0.100 |
Why?
|
| Nanoparticles | 2 | 2017 | 544 | 0.100 |
Why?
|
| Spectrum Analysis | 1 | 2013 | 50 | 0.100 |
Why?
|
| Signal Transduction | 2 | 2019 | 3145 | 0.090 |
Why?
|
| Aged, 80 and over | 5 | 2025 | 5607 | 0.090 |
Why?
|
| Rabbits | 3 | 2017 | 338 | 0.090 |
Why?
|
| Infant | 3 | 2025 | 1693 | 0.090 |
Why?
|
| Fuzzy Logic | 1 | 2011 | 5 | 0.080 |
Why?
|
| Relative Biological Effectiveness | 2 | 2007 | 7 | 0.080 |
Why?
|
| Anisotropy | 1 | 2011 | 63 | 0.080 |
Why?
|
| Diffusion | 1 | 2011 | 82 | 0.080 |
Why?
|
| Child, Preschool | 3 | 2025 | 2061 | 0.080 |
Why?
|
| Embolization, Therapeutic | 1 | 2014 | 333 | 0.080 |
Why?
|
| Liver | 1 | 2015 | 869 | 0.080 |
Why?
|
| Organ Specificity | 2 | 2007 | 198 | 0.080 |
Why?
|
| Cluster Analysis | 1 | 2011 | 261 | 0.080 |
Why?
|
| Light | 1 | 2011 | 195 | 0.080 |
Why?
|
| Muscles | 1 | 2011 | 179 | 0.080 |
Why?
|
| Diagnosis, Differential | 2 | 2025 | 991 | 0.080 |
Why?
|
| Abdominal Pain | 2 | 2021 | 102 | 0.070 |
Why?
|
| Adipose Tissue | 1 | 2011 | 299 | 0.070 |
Why?
|
| Whole-Body Counting | 1 | 2007 | 4 | 0.070 |
Why?
|
| Vanadium Compounds | 2 | 2017 | 4 | 0.070 |
Why?
|
| Radiographic Magnification | 1 | 2007 | 2 | 0.070 |
Why?
|
| Acute Disease | 2 | 2019 | 663 | 0.070 |
Why?
|
| United States | 3 | 2026 | 8093 | 0.060 |
Why?
|
| Random Allocation | 2 | 2017 | 200 | 0.060 |
Why?
|
| Oxidation-Reduction | 2 | 2017 | 325 | 0.060 |
Why?
|
| Computer-Aided Design | 1 | 2006 | 27 | 0.060 |
Why?
|
| Surface Properties | 2 | 2017 | 283 | 0.060 |
Why?
|
| Surveys and Questionnaires | 2 | 2025 | 2763 | 0.060 |
Why?
|
| Time Factors | 3 | 2020 | 3762 | 0.060 |
Why?
|
| Atrophy | 1 | 2025 | 87 | 0.050 |
Why?
|
| Adiponectin | 1 | 2024 | 37 | 0.050 |
Why?
|
| Systems Theory | 1 | 2004 | 4 | 0.050 |
Why?
|
| Semiconductors | 1 | 2004 | 14 | 0.050 |
Why?
|
| Biophysical Phenomena | 1 | 2004 | 23 | 0.050 |
Why?
|
| Biophysics | 1 | 2004 | 42 | 0.050 |
Why?
|
| India | 1 | 2024 | 164 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2023 | 5784 | 0.050 |
Why?
|
| Carotid Artery, Internal | 1 | 2023 | 69 | 0.050 |
Why?
|
| Animals | 5 | 2019 | 21308 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2025 | 1113 | 0.040 |
Why?
|
| Prevalence | 1 | 2026 | 1445 | 0.040 |
Why?
|
| Job Satisfaction | 1 | 2022 | 142 | 0.040 |
Why?
|
| Physical Phenomena | 1 | 2000 | 9 | 0.040 |
Why?
|
| Physics | 1 | 2000 | 12 | 0.040 |
Why?
|
| Thrombectomy | 1 | 2023 | 254 | 0.040 |
Why?
|
| Diet | 1 | 2024 | 534 | 0.040 |
Why?
|
| Insulin | 1 | 2024 | 695 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2024 | 897 | 0.040 |
Why?
|
| Calibration | 1 | 2000 | 68 | 0.040 |
Why?
|
| Disease Progression | 1 | 2025 | 1219 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2021 | 278 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2007 | 2102 | 0.040 |
Why?
|
| Collateral Circulation | 1 | 2019 | 28 | 0.040 |
Why?
|
| Metabolic Detoxication, Phase I | 1 | 2019 | 1 | 0.040 |
Why?
|
| Leukocytes | 1 | 2019 | 105 | 0.040 |
Why?
|
| Breath Holding | 1 | 2018 | 7 | 0.040 |
Why?
|
| Valsalva Maneuver | 1 | 2018 | 11 | 0.040 |
Why?
|
| Glycosylation | 1 | 2019 | 138 | 0.040 |
Why?
|
| Rectal Prolapse | 1 | 2018 | 11 | 0.040 |
Why?
|
| Uterine Prolapse | 1 | 2018 | 17 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2018 | 65 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2018 | 72 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2018 | 75 | 0.030 |
Why?
|
| Multimodal Imaging | 1 | 2019 | 73 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2019 | 342 | 0.030 |
Why?
|
| Electrodes | 1 | 2017 | 39 | 0.030 |
Why?
|
| Serpins | 1 | 2018 | 18 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 204 | 0.030 |
Why?
|
| Nerve Growth Factors | 1 | 2018 | 28 | 0.030 |
Why?
|
| Inflammation | 1 | 2024 | 1187 | 0.030 |
Why?
|
| Phosphorus | 1 | 2017 | 16 | 0.030 |
Why?
|
| Body Burden | 2 | 2007 | 12 | 0.030 |
Why?
|
| Eye Proteins | 1 | 2018 | 73 | 0.030 |
Why?
|
| Pancreatic Elastase | 1 | 2017 | 32 | 0.030 |
Why?
|
| Choline | 1 | 2017 | 23 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 286 | 0.030 |
Why?
|
| Catalysis | 1 | 2017 | 163 | 0.030 |
Why?
|
| Angioplasty | 1 | 2017 | 53 | 0.030 |
Why?
|
| Glutathione | 1 | 2017 | 55 | 0.030 |
Why?
|
| Axilla | 1 | 2016 | 18 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2019 | 320 | 0.030 |
Why?
|
| Radiation Exposure | 1 | 2017 | 24 | 0.030 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2016 | 39 | 0.030 |
Why?
|
| Vascular Remodeling | 1 | 2016 | 23 | 0.030 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2016 | 67 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2016 | 29 | 0.030 |
Why?
|
| Chitosan | 1 | 2017 | 87 | 0.030 |
Why?
|
| Reference Values | 1 | 2017 | 327 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 2016 | 71 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2018 | 351 | 0.030 |
Why?
|
| Image-Guided Biopsy | 1 | 2015 | 50 | 0.030 |
Why?
|
| Cattle | 1 | 2015 | 320 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 372 | 0.030 |
Why?
|
| Needles | 1 | 2015 | 64 | 0.030 |
Why?
|
| Tomography, Optical Coherence | 1 | 2017 | 235 | 0.030 |
Why?
|
| Permeability | 1 | 2014 | 50 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2019 | 1420 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 1585 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 1785 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2015 | 123 | 0.030 |
Why?
|
| Risk Factors | 2 | 2018 | 5429 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 1559 | 0.020 |
Why?
|
| Risk | 1 | 2014 | 374 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2018 | 2188 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2019 | 1575 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2014 | 183 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 2483 | 0.020 |
Why?
|
| Patient Selection | 1 | 2015 | 483 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 1630 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 2619 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 3470 | 0.020 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2013 | 214 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 3307 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 1015 | 0.020 |
Why?
|
| Uterus | 1 | 2008 | 41 | 0.020 |
Why?
|
| Thymus Gland | 1 | 2008 | 240 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2008 | 152 | 0.020 |
Why?
|
| Information Storage and Retrieval | 1 | 2006 | 60 | 0.010 |
Why?
|
| Heart | 1 | 2008 | 297 | 0.010 |
Why?
|
| User-Computer Interface | 1 | 2005 | 126 | 0.010 |
Why?
|
| ROC Curve | 1 | 2005 | 292 | 0.010 |
Why?
|
| Data Compression | 1 | 2004 | 9 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2005 | 602 | 0.010 |
Why?
|
| Lung | 1 | 2008 | 962 | 0.010 |
Why?
|
| Software | 1 | 2004 | 400 | 0.010 |
Why?
|